Skip to main content
Dr. Andrew Craig appointed Director, Queen's Cancer Research Institute

On the recommendation of Dean Jane Philpott, Mark Green, Provost and Vice-Principal (Academic) at Queen’s University, has appointed Dr. Andrew Craig as Director, Queen’s Cancer Research Institute (QCRI). His five-year term began on January 1st, 2022.

Dr. Christopher Booth appointed to Director of our CCE Division!

Michael Brundage, MSc, FRCPC, MD (Interim Director, QCRI) has appointed Christopher Booth, MD, FRCPC as Director, CCE Division, QCRI.

Dr. Booth is a Medical Oncologist and Health Services Researcher. He is a Professor of Oncology and Public Health Sciences and holds the Canada Research Chair in Population Cancer Care.

The journey to ‘normal’: post-pandemic cancer care

The global pandemic has significantly disrupted health care around the world, including cancer diagnoses and treatments, leaving many patients waiting for care during an already anxious time. Now, as restrictions begin to ease, the work of managing the backlog of cases begins. As we journey to our new ‘normal’, what have we learned from the pandemic to guide our processes and prepare us for the next major event?


A huge congratulations to our CBG Division's Dr. Andrew Craig on obtaining a 5-year CIHR Project Grant entitled "Targeting TGF-beta signaling to achieve durable therapy responses in preclinical ovarian cancer models". 

Clinical Research Fellowship in Population Health and Cancer Outcomes

Clinical Research Fellowship in Population Health and Cancer Outcomes

Subscribe to Research news